Oropharyngeal Cancer Squamous Cell Carcinoma. Our experience and review of the literature

Authors

  • Iván Doménech Máñez Servicio de Otorrinolaringología H. General Universitario de Castellón, España
  • María Antón Almero Servicio de Otorrinolaringología H. General Universitario de Castellón, España
  • María José Ferrer Ramírez Servicio de Otorrinolaringología H. General Universitario de Castellón, España
  • Esteban Reig Montaner Servicio de Otorrinolaringología H. General Universitario de Castellón, España
  • Natalia Gordillo Gayo Servicio de Otorrinolaringología H. General Universitario de Castellón, España
  • Marta Faubel Serra Servicio de Otorrinolaringología H. General Universitario de Castellón, España

DOI:

https://doi.org/10.34631/sporl.941

Keywords:

Oropharyngeal squamous cell carcinoma, Epidemiology, Age, Toxic habits, Human papillomavirus.

Abstract

Objectives: to evaluate the epidemiological and clinical characteristics of patients with oropharyngeal cancer squamous cell carcinoma (OPSCC) in our series and to compare them with the literature.

Patients And Methods: We present an observational, prospective and non-randomized study, in which we include 38 patients diagnosed with OPSCC in our center over 5 years (2016-2020).

Results: Out of 168 patients with head and neck carcinoma, the 22.6% were diagnosed with OPSCC and the 31.6% with HPV. This subgroup is characterized for being patients younger than 59.1 years old, consuming less alcohol and/or tobacco and presenting carcinoma more frequently in the tonsil.

Conclusions: The OPSCC has increased in the past years, showing an increment in those associated with HPV. Our HPV positive patients have been diagnosed at an early stage, they were younger, healthier and additionally, had a better life expectancy.

References

International Agency for Research on Cancer, WHO. [cited 2020 Dec 7] Available from: http://globocan.iarc.fr.

De San José Llongueras S, García García AM. Virus del papiloma humano y cáncer: epidemiología y prevención. Madrid: EMISA; 2006.

Encuesta Nacional de Salud de España 2011/12, [cited 2020 Dec 7] available from: mscbs.gob.es/estadEstudios/estadisticas/encuestaNacional/encuesta2011.htm.

León X, López M, García J, Montserrat JR, Gras JR, Kolanczak KA. et al. Características epidemiológicas de los pacientes con carcinomas escamosos de cabeza y cuello. Resultados de un registro hospitalario. Acta Otorrinolaringol Esp. Sep-Oct 2019;70(5):272-278. doi: 10.1016/j.otorri.2018.05.006.

Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E. et al. Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States. J Clin Oncol. 2011 Nov 10;29(32):4294-301. doi: 10.1200/JCO.2011.36.4596.

Castellsagué X, Alemany L, Quer M, Halec G, Quirós B, Tous S. et al. HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 Patients. J Natl Cancer Inst. 2016 Jan 28;108(6):djv403. doi: 10.1093/jnci/djv403.

de Martel C, Georges D, Bray F, Ferlay J, Clifford GM. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob Health. 2020 Feb;8(2):e180-e190. doi: 10.1016/S2214-109X(19)30488-7.

Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR, Sullivan DC, Jessup JM, Brierley JD, Gaspar LE, Schilsky RL, Balch CM, Winchester DP, Asare EA, Madera M, Gress DM, Meyer LR. editors. AJCC Cancer Staging Manual, 8th ed. New York: Springer; 2017. XVII, 1032 p.

Warren S, Gates O. Multiple primary malignant tumors, a survey of the literature and statistical study. Am J Cancer. 1932;16:1358–1414.

Adelstein DJ, Rodriguez CP. Human Papillomavirus: Changing Paradigms in Oropharyngeal Cancer. Curr Oncol Rep. 2010 Mar;12(2):115-20. doi: 10.1007/s11912-010-0084-5.

De Souza DL, Curado MP, Bernal MM, Jerez Roig J. What is the future burden of HPV-related cancers in Spain? Clin Transl Oncol. 2014 Feb;16(2):213-9. doi: 10.1007/s12094-013-1064-7.

Cerezo L, de la Torre A, Hervás A, Ruiz A, Liñán O, López M. et al. Oropharyngeal cáncer related to Human Papilloma Virus: incidence and prognosis in Madrid, Spain. Clin Transl Oncol. 2014 Mar;16(3):301-6. doi: 10.1007/s12094-013-1074-5.

Mifsud M, Eskander A, Irish J, Gullane P, Gilbert R, Brown D. et al. Evolving trends in head and neck cancer epidemiology: Ontario, Canada 1993-2010. Head Neck. 2017 Sep;39(9):1770-1778. doi: 10.1002/hed.24829.

Braakhuis BJM, Leemans CR, Visser O. Incidence and survival trends of head and neck squamous cell carcinoma in the Netherlands between 1989 and 2011. Oral Oncol. 2014 Jul;50(7):670-5. doi: 10.1016/j.oraloncology.2014.03.008.

Pytynia KB, Dahlstrom KR, Sturgis EM. Epidemiology of HPV-associated oropharyngeal cancer. Oral Oncol. 2014 May;50(5):380-6. doi: 10.1016/j.oraloncology.2013.12.019.

Zafereo ME, Beadle BM, Weber RS. Carcinoma of the oropharynx. In: Mehanna HM, Ang KK. Head and Neck Cancer Recurrence: Evidence-based, Multidisciplinary Management. New York: Georg Thieme Verlag KG; 2012. p. 145-61.

Goodwin WJ. Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: when do the ends justify the means? Laryngoscope. 2000 Mar;110(3 Pt 2 Suppl 93):1-18. doi: 10.1097/00005537-200003001-00001.

Licitra L, Zigon G, Gatta G, Sánchez MJ, Berrino F, EUROCARE Working Group. Human papillomavirus in HNSCC: a European epidemiologic perspective. Hematol Oncol Clin North Am. 2008 Dec;22(6):1143-53, vii-viii. doi: 10.1016/j.hoc.2008.10.002.

Grimminger CM, Danenberg PV. Update of prognostic and predictive biomarkers in oropharyngeal squamous cell carcinoma: a review. Eur Arch Otorhinolaryngol. 2011 Jan;268(1):5-16. doi: 10.1007/s00405-010-1369-x.

Zafereo ME, Hanasono MM, Rosenthal DI, Sturgis EM, Lewin JS, Roberts DB. et al. The role of salvage surgery in patients with recurrent squamous cell carcinoma of the oropharynx. Cancer. 2009 Dec 15;115(24):5723-33. doi: 10.1002/cncr.24595.

Ghazal Asswad R, Alvi S, Davies K, Jones TM, Hamilton DW, Brammer C. et al. The role of multidisciplinary decision making in oropharyngeal cancer: do we follow guidelines and are treatment decisions being implemented? Eur Arch Otorhinolaryngol. 2020 Mar;277(3):947-952. doi: 10.1007/s00405-019-05781-2.

Yoshida EJ, Luu M, Mallen-St Clair J, Mita AC, Scher KS, Lu DJ, Nguyen AT. et al. Stage I HPV‐positive oropharyngeal cancer: Should all patients receive similar treatments? Cancer. 2020 Jan 1;126(1):58-66. doi: 10.1002/cncr.32501

Wirth LJ, Burtness B, Nathan CO, Grégoire V, Richmon J. Point/Counterpoint: Do We De-escalate Treatment of HPV-Associated Oropharynx Cancer Now? And How? Am Soc Clin Oncol Educ Book. 2019 Jan;39:364-372. doi: 10.1200/EDBK_238315.

Priante AV, Castilho EC, Kowalski LP. Second Primary Tumors in Patients with Head and Neck Cancer. Curr Oncol Rep. 2011 Apr;13(2):132-7. doi: 10.1007/s11912-010-0147-7.

Herranz González-Botas J, Varela Vázquez P, Vázquez Barro C. Segundos tumores primarios en cáncer de cabeza y cuello. Acta Otorrinolaringol Esp. May-Jun 2016;67(3):123-9. doi: 10.1016/j.otorri.2015.04.001.

Downloads

Published

2021-12-17

How to Cite

Doménech Máñez, I., Antón Almero, M. ., Ferrer Ramírez, M. J., Reig Montaner, E., Gordillo Gayo, N., & Faubel Serra, M. (2021). Oropharyngeal Cancer Squamous Cell Carcinoma. Our experience and review of the literature. Portuguese Journal of Otorhinolaryngology and Head and Neck Surgery, 59(4), 333–339. https://doi.org/10.34631/sporl.941

Issue

Vol. 59 No. 4 (2021): December

Section

Original Article

License

Copyright (c) 2021 Portuguese Journal of Otorhinolaryngology and Head and Neck Surgery

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.